With the continuous expansion of the global pharmaceutical market, small pharmaceutical companies occupy an increasingly important position in it. These companies usually focus on a certain disease or field, and develop innovative drugs to meet the needs of patients. In this context, dihydromyricetin, as an important hepatoprotective and anti-tumor effect, has attracted the attention of small pharmaceutical companies. This article will discuss the procurement of dihydromyricetin by a small pharmaceutical company in the United States from the perspective of procurement planning.
Supplier selection
Before purchasing Dihydromyricetin powder, it is necessary to choose a reliable supplier. In general, the following factors need to be considered when selecting a supplier:
1. Product quality: Dihydromyricetin is a key anti-tumor drug, and product quality must be guaranteed. Therefore, the supplier's quality management system, production process and quality control process must comply with international standards.
2. Supply Reliability: Suppliers must be able to deliver on time and have a stable supply capacity. When selecting a supplier, it is necessary to examine its supply capacity and supply records.
3. Price competitiveness: Small pharmaceutical companies often have limited budgets and need to find competitive prices without compromising quality and reliability.
4. Service quality: Suppliers should provide timely technical support and after-sales service to ensure the progress of production and R&D.
Based on the above considerations, we recommend choosing a supplier with a certain scale and stable supply capacity to ensure product quality and reliability. At the same time, it is also necessary to establish a set of evaluation criteria in terms of price and service quality to provide reference for the final selection of suppliers.
Determination of purchase quantity
Determining the purchase quantity is a key step, which needs to be determined according to the company's R&D plan and production needs. In general, companies need to consider the following factors:
1. Cost and benefit: The price of dihydromyricetin is relatively high. Small pharmaceutical companies need to consider the balance between purchase volume and cost while ensuring product quality and R&D progress to ensure maximum revenue.
2. Production cycle and inventory: Enterprises need to consider the impact of production cycle and inventory to avoid inventory backlog and delay production.
3. Risk control: Potential risk factors, such as international situation, market supply and demand relationship, etc., need to be taken into account in order to ensure the timeliness and accuracy of procurement decisions.
When enterprises determine the purchase volume, they need to comprehensively consider the above factors, establish a set of quantitative evaluation standards, and provide scientific basis.
Signing of the purchase contract
After selecting a supplier and determining the purchase volume, the enterprise needs to sign a purchase contract with the supplier. This process needs to pay attention to the following points:
1. The contract terms must be detailed: The contract terms must take into account all possible risks and variables, such as delivery date, quality standard, price, payment terms, liability for breach of contract, etc., to ensure that the rights and interests of the enterprise are protected.
2. The content of the contract needs to be clear: the contract should directly express the responsibilities of both parties to avoid future disputes.
3. Risk control: Procurement contracts should also consider potential risk factors, such as changes in market supply and demand, logistics and transportation issues, policies and regulations, etc., to ensure that the company's procurement results are maximized.
In short, when purchasing dihydromyricetin, small pharmaceutical companies need to carefully consider supplier selection, purchase quantity confirmation, and purchase contract signing, which will help improve the company's ability to resist risks and maximize benefits.
Why choose KINTAI?
KINTAI is a biotechnology company that produces and sells dihydromyricetin as its main product. Dihydromyricetin is a natural active compound with various pharmacological effects, which has been widely used in medicine, health products, cosmetics and other fields. Founded in 2010, KINTAI has rich experience in production and sales, and is committed to providing customers with the best quality products and services.
The raw materials for the production of dihydromyricetin are collected through a very strict and standardized process at the place of origin. KINTAI's dihydromyricetin undergoes multiple processes such as wet extraction to extract high-purity dihydromyricetin. Throughout the process, we strictly abide by GMP and other quality standards to ensure product quality and safety.
TIPS
If you have interests in our Dihydromyricetin powder, please feel free to contact us at sales@kintaibio.com or feedback in next page.
WhatsApp:+86 177 8273 6795
More details,please check www.kintai-bio.com.
